Insider Transactions in Q1 2021 at Bolt Biotherapeutics, Inc. (BOLT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400,000
+8.16%
|
$8,000,000
$20.0 P/Share
|
|
Feb 09
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,027,088
+49.53%
|
-
|
|
Feb 09
2021
|
Randall C Schatzman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+50.0%
|
$30,000
$20.0 P/Share
|
|
Feb 09
2021
|
William P. Quinn President, CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,200
+7.95%
|
$24,000
$20.0 P/Share
|
|
Feb 09
2021
|
Edgar Engleman Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+8.09%
|
$4,000,000
$20.0 P/Share
|
|
Feb 09
2021
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
164
-0.01%
|
$3,280
$20.0 P/Share
|
|
Feb 09
2021
|
Edgar Engleman Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
46,608
+2.2%
|
$0
$0.07 P/Share
|
|
Feb 09
2021
|
Edgar Engleman Director |
BUY
Conversion of derivative security
|
Indirect |
1,997,991
+27.94%
|
-
|
|
Feb 09
2021
|
Ashish Siri Ram Khanna Director |
BUY
Open market or private purchase
|
Indirect |
1,200
+50.0%
|
$24,000
$20.0 P/Share
|
|
Feb 09
2021
|
Ashish Siri Ram Khanna Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$20,000
$20.0 P/Share
|
|
Feb 09
2021
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
450,000
+14.04%
|
$9,000,000
$20.0 P/Share
|
|
Feb 09
2021
|
James Healy |
BUY
Conversion of derivative security
|
Indirect |
2,304,437
+42.12%
|
-
|
|
Feb 09
2021
|
Mahendra Shah |
SELL
Open market or private sale
|
Indirect |
62
-0.0%
|
$1,240
$20.0 P/Share
|
|
Feb 09
2021
|
Mahendra Shah |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
17,711
+1.21%
|
$0
$0.07 P/Share
|
|
Feb 09
2021
|
Mahendra Shah |
BUY
Conversion of derivative security
|
Indirect |
1,416,352
+37.22%
|
-
|
|
Feb 09
2021
|
Kathleen Laporte |
BUY
Open market or private purchase
|
Direct |
1,200
+50.0%
|
$24,000
$20.0 P/Share
|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
350,000
+22.06%
|
$7,000,000
$20.0 P/Share
|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
226
-0.01%
|
$4,520
$20.0 P/Share
|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
64,319
+1.87%
|
$0
$0.07 P/Share
|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,414,343
+30.26%
|
-
|
|
Feb 09
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450,000
+14.04%
|
$9,000,000
$20.0 P/Share
|
|
Feb 09
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,304,437
+42.12%
|
-
|